ESDPPP – European Society for Developmental Perinatal and Paediatric Pharmacology

ESDPPP is a voluntary, non-profit association representing the interests of paediatric pharmacologists around the world.

Join  Our Webinar - 1st June, 10am

PRAGUE CONFERENCE 2023 - get registered!



Pavla Pokorna, our president will host this meeting from 28-30 June 2023 Prague, CZ  with a one-day pre-congress workshop on June 27th. The scientific program will be published by the end of April with exciting topics - from gene pharmacotherapy to machine learning and important updates regarding CTs, clinical pharmacology and European networks.


The registration for the societies next conference is open until  May 15th. Active participation with abstract submission is closed. 



We are already looking forward to the meeting and will do our best to celebrate the 

35th ESDPPPP anniversary in Prague with all of you.  


Stay tuned and visit our conference homepage for the latest details and information: 

ESDPPP Prague Congress 


Click here for general information (e.g.: contact,  venue, program etc.): 

Click here to get registered:

(active participation with abstract submission closed)

Please find the preliminary conference programme and all information for poster presenters below.


preliminary programme.pdf
Adobe Acrobat Document 458.5 KB
e-posters how to set up.pdf
Adobe Acrobat Document 306.6 KB

Webinar on Artificial Intelligence (AI) in Paediatrics 


Date: December 7th, 3-6pm (CET) 


The webinar is free of charge. Please register yourself by sending an email to



1) Matthias Schwab – introduction and moderator

2) Jolien Freriksen - Saskia de Wildt - “literature searches and AI”

3) Anke-Hilse Maitland van der Zee - topic “paediatric Asthma and AI”

4) Maaike van der Lee - “AI and drug metabolising enzymes”

5) Wei Zhao - “dose machine learning”

6) Dirk Lanzerath - “AI and ethical considerations”

Webinar Artificial Intelligence in Paedi
Adobe Acrobat Document 151.6 KB

General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products - Guidance for Industry, FDA

This guidance is intended to assist sponsors of investigational new drug applications and applicants of new drug applications, biologics license applications and supplements to such applications who are planning to conduct clinical studies in neonatal populations.

This guidance provides recommendations for neonatal clinical pharmacology studies and will be useful for education and practice.  


Additional tools (graphical snapshot, podcasts) can be found here: 

Guidance Snapshot Pilot | FDA



FDA 2022 Neonatalguidance_7.25.22.pdf
Adobe Acrobat Document 385.7 KB

Throwback: Liverpool Conference, June 2023

Our societies 19th Conference, hosted by our president Mark Turner in Liverpool, was a success and wonderful experience - especially to meet in-person again and to have the possibility to gain knowledge on-site after two predominant pandemic years.


Slides, posters and all abstracts will be provided in our "Members Only" area - have a look!


IUPHAR is responding to the current crisis by coordinating pharmacological resources worldwide. Although most of the current research is done in adults, we believe in part it may be relevant for pediatric pharmacologists as well.


Paediatric Pharmacology

Based in Ghent, Belgium, ESDPPP promotes research in developmental perinatal and paediatric pharmacology and offers a forum for dialogue between pharmacologists, clinicians, and scientists interested in the effect of medicines on the developing fetus, infant, and child.

35 years of ESDPPP

The ESDPPP celebrated its 35th anniversary in 2023. This milestone provides an important opportunity to celebrate ESDPPP’s achievements to date and to describe our future aspirations and ambitions on behalf of millions of paediatric patients worldwide.

Our aim

We aim to improve medicines for children and advance research and global access to paediatric medicines. We also advocate politically for the continued development of safe, evidence-based medications for children. In this respect, ESDPPP works closely with European Medicines Agency (EMA), International Union of Basic and Clinical Pharmacology (IUPHAR) and the World Health Organization (WHO).


Meeting our collegues is very important for our society. We enjoyed a wonderful congress in Liverpool, UK, in June 2022 and are looking forward to our next congress, which will be held in Prague (2023). We are welcoming your ideas and suggestions for these events.

Join us on LinkedIn!!

We want to use LinkedIn for announcements and discussions in our field. Please check out our group page on LinkedIn and become a group member.

ADC Journal

The official journal of the ESDPPP is the leading paediatric journal Archives of Disease in Childhood. It contains a Drug Therapy section which is published every 3 months.


ESDPPP is associated with a range of organizations like EMEA, IUHAR and WHO. Additional information  on projects, initiatives and conferences will be available within short.

35 Years ESDPPP

In 2023 ESDPPP celebrated its 35th anniversary at the society's 20th conference in Prague, CZ. The meeting will be hosted by our new president Pavla Pokorna. 

After the congress

Our last congress in Liverpool was a great success and a meeting place for many. Did you enjoy it as well? Become a member of ESDPPP and be the first to know more about the next congress in Prague…